Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heuser

Showing results (231-240 of 280) with videos related to

Pageof 28
Sort By:
Blood|September 27, 2019
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study GroupFrank G Rücker, Mridul Agrawal, Andrea Corbacioglu, et al.
Molecular Therapy. Methods & Clinical Development|June 7, 2021
Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvLJulia K Bialek-Waldmann, Sabine Domning, Ruth Esser, et al.
Haematologica|January 5, 2023
Activity of decitabine combined with all-<i>trans</i> retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER)Christoph Rummelt, Olga Grishina, Claudia Schmoor, et al.
Cell Stem Cell|May 8, 2026
Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AMLAlexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
The New England Journal of Medicine|June 9, 2016
Genomic Classification and Prognosis in Acute Myeloid LeukemiaElli Papaemmanuil, Moritz Gerstung, Lars Bullinger, et al.
Molecular Cancer|December 4, 2023
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemiaNuria Tubío-Santamaría, Ashok Kumar Jayavelu, Tina M Schnoeder, et al.
American Journal of Hematology|February 15, 2024
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysisNico Gagelmann, Gabriela S Hobbs, Edoardo Campodonico, et al.
Blood|February 18, 2021
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurinLaura K Schmalbrock, Anna Dolnik, Sibylle Cocciardi, et al.
Blood Advances|February 6, 2025
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNetAdriano Venditti, Raffaele Palmieri, Luca Maurillo, et al.
Blood Advances|April 29, 2022
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplicationsHartmut Döhner, Daniela Weber, Julia Krzykalla, et al.
Pageof 28

Showing results (231-240 of 280) with videos related to

Sort By:
Pageof 28
Blood|September 27, 2019
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study GroupFrank G Rücker, Mridul Agrawal, Andrea Corbacioglu, et al.
Molecular Therapy. Methods & Clinical Development|June 7, 2021
Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvLJulia K Bialek-Waldmann, Sabine Domning, Ruth Esser, et al.
Haematologica|January 5, 2023
Activity of decitabine combined with all-<i>trans</i> retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER)Christoph Rummelt, Olga Grishina, Claudia Schmoor, et al.
Cell Stem Cell|May 8, 2026
Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AMLAlexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
The New England Journal of Medicine|June 9, 2016
Genomic Classification and Prognosis in Acute Myeloid LeukemiaElli Papaemmanuil, Moritz Gerstung, Lars Bullinger, et al.
Molecular Cancer|December 4, 2023
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemiaNuria Tubío-Santamaría, Ashok Kumar Jayavelu, Tina M Schnoeder, et al.
American Journal of Hematology|February 15, 2024
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysisNico Gagelmann, Gabriela S Hobbs, Edoardo Campodonico, et al.
Blood|February 18, 2021
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurinLaura K Schmalbrock, Anna Dolnik, Sibylle Cocciardi, et al.
Blood Advances|February 6, 2025
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNetAdriano Venditti, Raffaele Palmieri, Luca Maurillo, et al.
Blood Advances|April 29, 2022
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplicationsHartmut Döhner, Daniela Weber, Julia Krzykalla, et al.
Pageof 28